Preview

Medical Genetics

Advanced search

Methylation of PNPLA2 lipase gene in atherosclerosis

https://doi.org/10.1234/XXXX-XXXX-2016-5-15-17

Abstract

One of the key components in the development of atherosclerosis is the metabolic imbalance of lipids. However, the role of epigenetic mechanisms in this process is studied insufficiently. The aim of our study was to characterize variability of the PNPLA2 lipase gene methylation in the cells of differently localized arteries and peripheral blood leukocytes in atherosclerosis. Materials and methods. Using bisulfite pyrosequencing, we performed the assessment of DNA methylation level in atherosclerotic plaques of coronary and carotid arteries, and in the wall of unaffected internal thoracic arteries, and in peripheral blood leukocytes of patients with atherosclerosis. Statistical data analysis was performed in R software environment. Results and conclusions. Cells of coronary atherosclerotic plaques were found to have higher levels of methylation in the promoter of PNPLA2 gene compared to unaffected wall of internal thoracic arteries. Methylation level of analyzed gene region in leukocytes of patients with atherosclerosis was associated with smoking and statins.

About the Authors

A. V. Markov
Research Institute of Medical Genetics, Tomsk NRMC; National Research Tomsk State University
Russian Federation


M. S. Nazarenko
Research Institute of Medical Genetics, Tomsk NRMC; National Research Tomsk State University
Russian Federation


E. O. Churkin
Siberian State Medical University
Russian Federation


O. L. Barbarash
Institute for Complex Issues of Cardiovascular Diseases
Russian Federation


V. P. Puzyrev
Research Institute of Medical Genetics, Tomsk NRMC; National Research Tomsk State University; Siberian State Medical University
Russian Federation


References

1. Аронов ДМ, Лупанов ВП. Некоторые аспекты патогенеза атеросклероза. Атеросклероз и дислипидемии. 2011;1:48-56.

2. Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011 May 19;473(7347):317-25.

3. Napoli C, Crudele V, Soricelli A et al. Primary prevention of atherosclerosis: a clinical challenge for the reversal of epigenetic mechanisms? Circulation. 2012 15;125(19):2363-2373.

4. Grimaldi V, Vietri MT, Schiano C et al. Epigenetic reprogramming in atherosclerosis. Curr Atheroscler Rep. 2015;17(2):476.

5. Young SG, Zechner R. Biochemistry and pathophysiology of intravascular and intracellular lipolysis. Genes Dev. 2013 Mar 1;27(5):459-484.

6. Hirano K, Ikeda Y, Zaima N et al. Triglyceride deposit cardiomyovasculopathy. N Engl J Med. 2008;359(22):2396-2398.

7. Пузырев ВП, Назаренко МС, Лебедев ИН и др. Феномен парадоминантного наследования при атеросклерозе. Медицинская генетика. 2014;10:41-48.

8. R Core Team (2016). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-project.org/.

9. Холлендер М, Вульф ДА. Непараметрические методы статистики. М.: Финансы и статистика. 1983;86-92.

10. Radovic B, Aflaki E, Kratky D. Adipose triglyceride lipase in immune response, inflammation, and atherosclerosis. Biol Chem. 2012;393(9):1005-11.


Review

For citations:


Markov A.V., Nazarenko M.S., Churkin E.O., Barbarash O.L., Puzyrev V.P. Methylation of PNPLA2 lipase gene in atherosclerosis. Medical Genetics. 2016;15(5):15-17. (In Russ.) https://doi.org/10.1234/XXXX-XXXX-2016-5-15-17

Views: 614


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2073-7998 (Print)